XERS - Xeris Biopharma Holdings Inc
IEX Last Trade
2.805
0.005 0.178%
Share volume: 781,944
Last Updated: Fri 30 Aug 2024 09:59:47 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$2.80
0.01
0.18%
Fundamental analysis
30%
Profitability
15%
Dept financing
25%
Liquidity
75%
Performance
35%
Performance
5 Days
-2.43%
1 Month
13.31%
3 Months
26.58%
6 Months
-6.95%
1 Year
22.71%
2 Year
74.53%
Key data
Stock price
$2.80
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.46 - $3.26
52 WEEK CHANGE
$0.19
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO:
Region: US
Website: xerispharma.com
Employees: 360
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: xerispharma.com
Employees: 360
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
xeris aspires to break through this restraint by developing ultra-low volume, ready-to-use biotherapeutics delivered through patient-friendly injectable devices. products built on our xeriject technologies could potentially ease the pain of injections for hundreds of millions of patients.
Recent news